Cannabis use and risk of lung cancer: a case-control study
- PMID: 18238947
- PMCID: PMC2516340
- DOI: 10.1183/09031936.00065707
Cannabis use and risk of lung cancer: a case-control study
Abstract
The aim of the present study was to determine the risk of lung cancer associated with cannabis smoking. A case-control study of lung cancer in adults <or=55 yrs of age was conducted in eight district health boards in New Zealand. Cases were identified from the New Zealand Cancer Registry and hospital databases. Controls were randomly selected from the electoral roll, with frequency matching to cases in 5-yr age groups and district health boards. Interviewer-administered questionnaires were used to assess possible risk factors, including cannabis use. The relative risk of lung cancer associated with cannabis smoking was estimated by logistic regression. In total, 79 cases of lung cancer and 324 controls were included in the study. The risk of lung cancer increased 8% (95% confidence interval (CI) 2-15) for each joint-yr of cannabis smoking, after adjustment for confounding variables including cigarette smoking, and 7% (95% CI 5-9) for each pack-yr of cigarette smoking, after adjustment for confounding variables including cannabis smoking. The highest tertile of cannabis use was associated with an increased risk of lung cancer (relative risk 5.7 (95% CI 1.5-21.6)), after adjustment for confounding variables including cigarette smoking. In conclusion, the results of the present study indicate that long-term cannabis use increases the risk of lung cancer in young adults.
Comment in
-
Cannabis: the next villain on the lung cancer battlefield?Eur Respir J. 2008 Feb;31(2):227-8. doi: 10.1183/09031936.00157607. Eur Respir J. 2008. PMID: 18238942 No abstract available.
-
Cannabis and lung cancer.Eur Respir J. 2008 Jul;32(1):238-9. doi: 10.1183/09031936.00024408. Eur Respir J. 2008. PMID: 18591344 No abstract available.
-
Doubts about the role of cannabis in causing lung cancer.Eur Respir J. 2008 Sep;32(3):815-6. doi: 10.1183/09031936.00051108. Eur Respir J. 2008. PMID: 18757709 No abstract available.
References
-
- Hoffmann D, Brunnerman D, Gori G, Wynder E. On the carcinogenicity of marijuana smoke. Recent Advances Phytochem. 1975;9:63–81. - PubMed
-
- Rickert W, Robinson J, Rogers B. A comparison of tar, carbon monoxide and pH levels in smoke from marijuana and tobacco cigarettes. Can J Pub Health. 1982;73:386–91. - PubMed
-
- Tashkin D, Gliederer F, Rose J, et al. Tar, CO and THC delivery from the 1st and 2nd halves of a marijuana cigarette. Pharmacol Biochem Behav. 1991;40:657–61. - PubMed
-
- Wu T, Tashkin D, Djahed B, Rose J. Pulmonary hazards of smoking marijuana as compared with tobacco. N Engl J Med. 1988;318:347–51. - PubMed
-
- Fligiel S, Roth M, Kleerup E, Barsky S, Simmons M, Tashkin D. Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco. Chest. 1997;112:319–26. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical